Cargando…

“Therapeutic” facemasks

There must be pathophysiological reason why “cold” viruses like SARS-CoV-2 show proclivity to nasal cavity, oral cavity, pharyngeal cavity and upper airways which have lower temperature than core body temperature. Henceforth, facemasks’ “therapeutic” role against SARS-CoV-2 must be explored because...

Descripción completa

Detalles Bibliográficos
Autor principal: Gupta, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236693/
https://www.ncbi.nlm.nih.gov/pubmed/32460210
http://dx.doi.org/10.1016/j.mehy.2020.109855
_version_ 1783536195013181440
author Gupta, Deepak
author_facet Gupta, Deepak
author_sort Gupta, Deepak
collection PubMed
description There must be pathophysiological reason why “cold” viruses like SARS-CoV-2 show proclivity to nasal cavity, oral cavity, pharyngeal cavity and upper airways which have lower temperature than core body temperature. Henceforth, facemasks’ “therapeutic” role against SARS-CoV-2 must be explored because personal “therapeutic” environments may get created under facemasks due to rebreathing of ~95°F “hot” and ~80% “humid” exhalations which may constantly mitigate SARS-CoV-2 inside nasal cavity, oral cavity, pharyngeal cavity and upper airways.
format Online
Article
Text
id pubmed-7236693
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72366932020-05-19 “Therapeutic” facemasks Gupta, Deepak Med Hypotheses Letter to Editors There must be pathophysiological reason why “cold” viruses like SARS-CoV-2 show proclivity to nasal cavity, oral cavity, pharyngeal cavity and upper airways which have lower temperature than core body temperature. Henceforth, facemasks’ “therapeutic” role against SARS-CoV-2 must be explored because personal “therapeutic” environments may get created under facemasks due to rebreathing of ~95°F “hot” and ~80% “humid” exhalations which may constantly mitigate SARS-CoV-2 inside nasal cavity, oral cavity, pharyngeal cavity and upper airways. Elsevier Ltd. 2020-10 2020-05-19 /pmc/articles/PMC7236693/ /pubmed/32460210 http://dx.doi.org/10.1016/j.mehy.2020.109855 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to Editors
Gupta, Deepak
“Therapeutic” facemasks
title “Therapeutic” facemasks
title_full “Therapeutic” facemasks
title_fullStr “Therapeutic” facemasks
title_full_unstemmed “Therapeutic” facemasks
title_short “Therapeutic” facemasks
title_sort “therapeutic” facemasks
topic Letter to Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236693/
https://www.ncbi.nlm.nih.gov/pubmed/32460210
http://dx.doi.org/10.1016/j.mehy.2020.109855
work_keys_str_mv AT guptadeepak therapeuticfacemasks